Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page
- Check4 days agoChange DetectedThe page no longer displays the disease term 'Type 2 diabetes' in the study description and the Related Topics section has been removed, including the 'MedlinePlus Genetics' item. This reflects removal of a core disease descriptor and its related resources, affecting how the study is framed and navigated.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a small release update.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer has been updated to reflect a newer ClinicalTrials.gov interface/version revision (from v3.5.2 to v3.5.3).SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded related topics to the page: Type 2 diabetes and MedlinePlus Genetics. This aligns the page with the study's subject and improves navigation to related information.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now displays revision v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.0%

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.